Knowledge Hub

Global Markets Report For BioLingus AG - Product Pipeline Review - 2016

Press Release   •   Jan 23, 2017 04:49 EST

Global Markets Directs, BioLingus AG - Product Pipeline Review - 2016, provides an overview of the BioLingus AGs pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by BioLingus AG, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

View Report @


- The report provides a snapshot of the pipeline therapeutic landscape of BioLingus AG

- The report provides overview of BioLingus AG including its business description, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses BioLingus AGs pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features BioLingus AGs out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate BioLingus AGs strategic position with total access to detailed information on its product pipeline

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for BioLingus AG

- Identify potential new clients or partners in the target demographic

- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding BioLingus AGs pipeline depth and focus of pipeline therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Get Sample Copy Of This Report @

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

BioLingus AG Snapshot 6

BioLingus AG Overview 6

Key Facts 6

BioLingus AG - Research and Development Overview 7

Key Therapeutic Areas 7

BioLingus AG - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

BioLingus AG - Pipeline Products Glance 11

BioLingus AG - Early Stage Pipeline Products 11

Preclinical Products/Combination Treatment Modalities 11

Discovery Products/Combination Treatment Modalities 12

BioLingus AG - Unknown Stage Pipeline Products 13

Unknown Products/Combination Treatment Modalities 13

BioLingus AG - Drug Profiles 14

aldesleukin - Drug Profile 14

Product Description 14

Mechanism Of Action 14

R&D Progress 14

Cellular Immunotherapy to Target Survivin for Oncology - Drug Profile 15

Product Description 15

Mechanism Of Action 15

R&D Progress 15

exenatide biobetter - Drug Profile 16

Product Description 16

Mechanism Of Action 16

R&D Progress 16

interferon alfa biobetter - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

interferon gamma - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

interleukin 2 - Drug Profile 19

Product Description 19

Mechanism Of Action 19 is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.